Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.


Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63

Get in touch:

Contact Info:
Email: Send Email
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL:

For more information, please visit

Source: MarketersMedia

Release ID: 250082

More News From

US-Europe trade war likely averted, for now

Mar 22, 2018

BRUSSELS — The European Union and the U.S. seem to have averted a trade war for now, after the administration of President Donald Trump said Thursday it was ready to exempt the 28-country bloc from tariffs on steel and aluminum. EU leaders, who had threatened to retaliate to any new U.S. tariffs with restrictions on American goods, gave a cautious welcome to news of the exemption. "A trade war would have damaged both sides," Austrian Chancellor Sebastian Kurz tweeted from a summit of leaders in Brussels. In Washington, U.S. Trade Representative Robert Lighthizer said Thursday that Trump had decided to...

The Latest: Austria welcomes US exemption on tariffs

Mar 22, 2018

BRUSSELS — The Latest on the European Union leaders summit in Brussels (all times local): 4:55 p.m. Austrian Chancellor Sebastian Kurz has welcomed what he saw as a European Union exemption from the U.S. threat to impose steel and aluminum import tariffs. Kurz Tweeted from an EU summit that the U.S. move was "the result of the Europeans' clear position in the talks with the U.S. A trade war would have damaged both sides." In Washington, U.S. Trade Representative Robert Lighthizer spelled out which countries would get a "pause" from President Trump and get an early reprieve from the imposition...

6 dead, 2 hurt in Czech chemical factory explosion

Mar 22, 2018

PRAGUE — An explosion rocked a chemical factory Thursday in the Czech Republic, killing six people and injuring two others, officials said. Unipetrol, a Czech oil processor and plastics producer, said the blast took place inside one of the storage tank for fuels and additives in its refinery in the town of Kralupy nad Vltavou, 10 miles (16 kilometers) north of the capital Prague. It was not immediately clear what caused the blast. A Kralupy town crisis manager, Lukas Hodik, said the explosion seemed to occur when workers were cleaning an empty tank. Regional firefighters confirmed that six people were...

Kosovo parliament vote on border deal halted by tear gas

Mar 22, 2018

PRISTINA, Kosovo — Kosovo's opposition on Wednesday used tear gas to disrupt a parliament vote on a border demarcation deal with Montenegro. Lawmakers had to be evacuated from the Assembly building after the Self-Determination Movement party used tear gas in the hall where the vote was due to start Wednesday. The 120-seat parliament was expected to vote with two-thirds to ratify the 2015 deal, set as a precondition by the European Union for Kosovo's citizens to freely travel within its visa-free travel zone known as Schengen. The opposition party says the border deal would mean Kosovo loses 8,200 hectares (20,000...

EU approves Bayer takeover of Monsanto after concessions

Mar 22, 2018

BRUSSELS — The European Union has approved Bayer's buyout of Monsanto in a massive agriculture business deal, but says they will have to shed over $7.4 billion in firms and other remedies to ensure fair competition in the market. The $57 billion takeover has been watched by rivals and environmental groups, who are fearful that the number of players in the business of selling seeds and pesticides will shrink further and give one company a suffocating grip on the food chain. EU Antitrust Commissioner Margrethe Vestager said Wednesday that the remedies proposed by Bayer and Monsanto are worth well over...

Weather, 20 December
Houston Weather

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH

About Us

24-7 Reporters publishes up-to-the-minute news 24 hours a day, 7 days a week. Our certified reporters are among the most experienced, well-trained and talented across the globe, covering issues resonating progressives in every corner of the world.

Contact us: